

A former soccer boss gets a pelting, plus a costly name change and tough-to-swallow tariffs.


A former soccer boss gets a pelting, plus a costly name change and tough-to-swallow tariffs.
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for …